January 22, 2018 08:16 AM ESTUpdated 09:02 AM
People

Hep­tares co-founder Fiona Mar­shall grabs the helm at Mer­ck­'s up­com­ing UK drug dis­cov­ery cen­ter

Amber Tong

 

In a boost to its planned $1.3 bil­lion UK drug re­search hub and head­quar­ters, Mer­ck an­nounced to­day that it has re­cruit­ed the not­ed British …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Bris­tol My­ers re­veals more job cuts in New Jer­sey

Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

In­cyte touts Mon­ju­vi da­ta from Phase 3 fol­lic­u­lar lym­phoma tri­al as it heads to FDA

Gilead buys ex­per­i­men­tal HIV vac­cines from a small Barcelona biotech

A service from the Financial Times